Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruiting

Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)

NCT04022460
completednot_applicable

Disparities in National Kidney Allocation Policy

NCT02879812
completednot_applicable

Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone

NCT05093309

Clinical Trials (3)

Showing 3 of 3 trials
NCT04022460

Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)

Active Not Recruiting
NCT02879812Not Applicable

Disparities in National Kidney Allocation Policy

Completed
NCT05093309Not Applicable

Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3